Epigenomics AG (LON: 0QXH)
London
· Delayed Price · Currency is GBP · Price in EUR
1.110
0.00 (0.00%)
At close: Dec 23, 2024
Epigenomics AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1.21 | 2.1 | 7.8 | 23.05 | 3.57 | 10.16 | Upgrade
|
Short-Term Investments | - | - | - | - | 0.96 | 0.88 | Upgrade
|
Cash & Short-Term Investments | 1.21 | 2.1 | 7.8 | 23.05 | 4.53 | 11.04 | Upgrade
|
Cash Growth | -66.32% | -73.04% | -66.14% | 409.15% | -58.98% | -35.62% | Upgrade
|
Accounts Receivable | - | 0.3 | 0.05 | 0.07 | 0.25 | 0.09 | Upgrade
|
Other Receivables | - | - | - | 0.13 | 0.22 | 0.38 | Upgrade
|
Receivables | - | 0.3 | 0.05 | 0.2 | 0.47 | 0.47 | Upgrade
|
Inventory | - | - | 0.04 | 0.18 | 0.12 | 0.31 | Upgrade
|
Prepaid Expenses | - | - | - | 0.22 | 0.31 | 0.27 | Upgrade
|
Other Current Assets | 0.34 | 0.08 | 0.23 | 0.06 | 0.03 | 0.03 | Upgrade
|
Total Current Assets | 1.54 | 2.49 | 8.12 | 23.71 | 5.47 | 12.12 | Upgrade
|
Property, Plant & Equipment | - | 0 | 0.57 | 0.89 | 1.18 | 1.53 | Upgrade
|
Long-Term Investments | 2.1 | 2.28 | 0.79 | - | - | - | Upgrade
|
Other Intangible Assets | - | 0.01 | 0.03 | 0.01 | 0.05 | 0.12 | Upgrade
|
Long-Term Deferred Charges | - | - | - | 0.05 | 0.09 | 0.21 | Upgrade
|
Other Long-Term Assets | 8.4 | 8.07 | 4.48 | - | - | - | Upgrade
|
Total Assets | 12.04 | 12.84 | 13.99 | 24.66 | 6.8 | 13.99 | Upgrade
|
Accounts Payable | 0 | 0.26 | 0.53 | 0.5 | 0.63 | 1.43 | Upgrade
|
Accrued Expenses | - | - | 0.05 | 1.25 | 1.2 | 1.31 | Upgrade
|
Current Portion of Leases | - | - | - | 0.09 | 0.22 | 0.22 | Upgrade
|
Current Income Taxes Payable | 0.03 | 0.02 | 0.06 | 0.06 | 0.03 | 0.07 | Upgrade
|
Current Unearned Revenue | - | - | - | 0.07 | 0.08 | 0.01 | Upgrade
|
Other Current Liabilities | - | - | - | 0.17 | 0.27 | 0.59 | Upgrade
|
Total Current Liabilities | 0.03 | 0.28 | 0.64 | 2.14 | 2.44 | 3.62 | Upgrade
|
Long-Term Debt | 11.42 | 11.89 | 12.66 | - | - | - | Upgrade
|
Long-Term Leases | - | - | - | 0.37 | 0.46 | 0.7 | Upgrade
|
Other Long-Term Liabilities | 8.93 | 8.7 | 5.01 | 0.03 | 0.04 | 0.04 | Upgrade
|
Total Liabilities | 20.38 | 20.86 | 18.31 | 2.54 | 2.93 | 4.36 | Upgrade
|
Common Stock | 0.88 | 0.85 | 4.09 | 15.54 | 5.89 | 43.53 | Upgrade
|
Retained Earnings | -86.25 | -85.46 | -84.41 | -93.16 | -90.73 | -102.83 | Upgrade
|
Comprehensive Income & Other | 77.03 | 76.59 | 75.99 | 99.74 | 88.71 | 68.93 | Upgrade
|
Shareholders' Equity | -8.34 | -8.02 | -4.32 | 22.12 | 3.86 | 9.63 | Upgrade
|
Total Liabilities & Equity | 12.04 | 12.84 | 13.99 | 24.66 | 6.8 | 13.99 | Upgrade
|
Total Debt | 11.42 | 11.89 | 12.66 | 0.46 | 0.68 | 0.91 | Upgrade
|
Net Cash (Debt) | -10.21 | -9.78 | -4.85 | 22.59 | 3.84 | 10.12 | Upgrade
|
Net Cash Growth | - | - | - | 487.64% | -62.02% | -40.95% | Upgrade
|
Net Cash Per Share | -11.67 | -11.47 | -5.97 | 40.31 | 13.30 | 43.45 | Upgrade
|
Filing Date Shares Outstanding | 0.88 | 0.85 | 0.82 | 0.78 | 0.29 | 0.27 | Upgrade
|
Total Common Shares Outstanding | 0.88 | 0.85 | 0.82 | 0.78 | 0.29 | 0.27 | Upgrade
|
Working Capital | 1.51 | 2.21 | 7.48 | 21.57 | 3.03 | 8.5 | Upgrade
|
Book Value Per Share | -9.53 | -9.39 | -5.28 | 28.47 | 13.12 | 35.39 | Upgrade
|
Tangible Book Value | -8.34 | -8.02 | -4.35 | 22.11 | 3.81 | 9.51 | Upgrade
|
Tangible Book Value Per Share | -9.53 | -9.40 | -5.31 | 28.45 | 12.94 | 34.95 | Upgrade
|
Machinery | - | 0.05 | 1.82 | 1.86 | 1.85 | 1.9 | Upgrade
|
Leasehold Improvements | - | - | 0.85 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.